Naturewise Biotech & Medicals Corporation(TW:4732)
NT$15.20+0.30 (+2.01%)
TW:4732
Naturewise Biotech & Medicals Corporation financials statements
NT$15.20
At close:+0.30 (+2.01%)
Naturewise Biotech & Medicals Corporation (4732) Income Statement
Naturewise Biotech & Medicals Corporation Income Statement
Last quarter (Q2 2026), Naturewise Biotech & Medicals Corporation's total revenue was NT$84.62M, a decrease of 35.30% from the same quarter last year. In Q2, Naturewise Biotech & Medicals Corporation's net income was NT$-70.27M. See Naturewise Biotech & Medicals Corporation’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 176.77M | NT$ 224.32M | NT$ 160.14M | NT$ 228.59M | NT$ 249.80M | |
| NT$ 85.70M | NT$ 120.20M | NT$ 87.38M | NT$ 118.99M | NT$ 134.90M | |
| NT$ 192.56M | NT$ 132.24M | NT$ 83.94M | NT$ 103.55M | NT$ 119.21M | |
| Depreciation and Amortization | NT$ 11.06M | NT$ 11.01M | NT$ 10.42M | NT$ 10.94M | NT$ 11.29M |
| NT$ -95.81M | NT$ 7.46M | NT$ 20.39M | NT$ 37.29M | NT$ 38.27M | |
| NT$ -106.87M | NT$ -12.04M | NT$ 3.43M | NT$ 26.35M | NT$ 26.98M | |
| NT$ 5.33M | NT$ 8.39M | NT$ 6.49M | NT$ 3.68M | NT$ 3.66M | |
| NT$ -101.54M | NT$ -3.65M | NT$ 9.92M | NT$ 30.02M | NT$ 30.64M | |
| NT$ -118.43M | NT$ 897.00K | NT$ 10.12M | NT$ 30.02M | NT$ 30.81M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.89 | NT$ 0.02 | NT$ 0.20 | NT$ 0.61 | NT$ 0.62 |
| Diluted EPS | NT$ -1.89 | NT$ 0.02 | NT$ 0.20 | NT$ 0.61 | NT$ 0.62 |
| Weighted Average Shares Outstanding | 48.83M | 49.84M | 49.91M | 49.29M | 49.34M |
| Weighted Average Shares Outstanding (Diluted) | 48.83M | 49.84M | 49.91M | 49.48M | 49.34M |
Currency in TWD
